Britch, Stevie C.
Walsh, Sharon L.
Funding for this research was provided by:
National Institute on Drug Abuse (R01 DA016718, T32 DA035200)
Article History
Received: 25 September 2021
Accepted: 18 March 2022
First Online: 7 April 2022
Declarations
:
: Sharon Walsh serves on a Scientific Advisory Board for Opiant Pharmaceuticals and as an advisor for Pocket Naloxone.
Free to read: This content has been made available to all.